# Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung Cancer

> **NCT00003696** · PHASE3 · UNKNOWN · sponsor: **Commissie Voor Klinisch Toegepast Onderzoek** · enrollment: 250 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** cyclophosphamide
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** etoposide
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00003696
- **Lead sponsor:** Commissie Voor Klinisch Toegepast Onderzoek
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1998-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2013-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003696, "Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*